Center-Authored Papers

Filters: Author is Westervelt, Peter  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
Lee S, Flowers ME, Martin PJ, Carpenter P, Hansen J, Chai X, Kurland B, Storer B, Arai S, Johnston L et al..  2011.  Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1114-20. Abstract
Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE et al..  2016.  Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial.. JAMA oncology. Abstract
K
Klco JM, Miller CA, Griffith M, Petti A, Spencer DH, Ketkar-Kulkarni S, Wartman LD, Christopher M, Lamprecht TL, Helton NM et al..  2015.  Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia.. JAMA. 314(8):811-22. Abstract
G
Greenberg PL, Stone RM, Bejar R, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, DeZern AE, Fathi AT et al..  2015.  Myelodysplastic syndromes, version 2.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(3):261-72. Abstract
Greenberg PL, Stone RM, Al-Kali A, Barta SK, Bejar R, Bennett JM, Carraway H, De Castro CM, Deeg HJ, DeZern AE et al..  2017.  Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 15(1):60-87. Abstract
Greenberg PL, Attar E, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, Frankfurt O, Gaensler K, Garcia-Manero G et al..  2013.  Myelodysplastic syndromes: clinical practice guidelines in oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(7):838-74. Abstract
Greenberg PL, Attar E, Bennett JM, Bloomfield CD, De Castro CM, Deeg HJ, Foran JM, Gaensler K, Garcia-Manero G, Gore SD et al..  2011.  Myelodysplastic syndromes.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(1):30-56. Abstract
C
Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ et al..  2011.  Myeloid growth factors.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(8):914-32.
Crawford J, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP, Foran J et al..  2009.  Myeloid growth factors.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(1):64-83.
Crawford J, Althaus B, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP et al..  2007.  Myeloid growth factors. Clinical practice guidelines in oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 5(2):188-202.
Crawford J, Armitage J, Balducci L, Becker PS, Blayney DW, Cataland SR, Heaney ML, Hudock S, Kloth DD, Kuter DJ et al..  2013.  Myeloid growth factors.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(10):1266-90. Abstract
B
Bolaños-Meade J, Logan BR, Alousi AM, Antin JH, Barowski K, Carter SL, Goldstein SC, Hexner EO, Horowitz MM, Lee SJ et al..  2014.  Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802.. Blood. 124(22):3221-7;quiz3335. Abstract
A
Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S et al..  2012.  Peripheral-blood stem cells versus bone marrow from unrelated donors.. The New England journal of medicine. 367(16):1487-96. Abstract